Dee Chaudhary
Director, Consulting
With more than 25 years in life sciences and a passion for patients, Dee Chaudhary is a Director with Clarivate’s Commercial Strategy Consulting practice. Her work in consulting, and within the biopharmaceutical industry has primarily focused on HUB/patient services, launch readiness, CMS policy impact, customer experience and market access strategy in the hematology and oncology space.
Dee has extensive professional experience with 340B pricing, reimbursement strategy, product positioning and value propositions for oral and infusible agents. She has led HUB migrations, benchmarking engagements, customer satisfaction projects, omni-channel projects, product differentiation, pricing and positioning efforts, and payer landscape analysis. Furthermore, Dee has an in-depth understanding of the hematology and oncology market landscape, targeted and cellular therapies, and has a strong interest and experience in other therapeutic areas including cardiology, neuroscience, med tech immunotherapy, and using technology to advance health and access. She has been invited to presented at Asembia, ISPOR and other clinical meetings, and has authored multiple trainings and white papers.
Prior to joining Clarivate, Dee held a variety roles at small and large biopharmaceutical organizations and consulting firms, including National Director of Market Access, Reimbursement and Trade, Senior Director of Customer Experience, and Assistant Director of Reimbursement Consulting. Dee holds a BA from Gustavus Adolphus College in History, and an MBA in Healthcare Administration.
Latest news
Clarivate Selected by University of Texas at Dallas Libraries to Provide Alma Specto
Alma Specto, an AI-native digital collection and exhibition platform offers UT Dallas Libraries a scalable, flexible and future-ready solution, expanding the reach of its Special Collections to new audiences London,…
Clarivate Reveals the AI50 – the Organizations Leading Artificial Intelligence Invention
London, U.K. March, 26, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the Clarivate AI50, a new data-driven benchmark of organizations demonstrating exceptional leadership in…
Annual Report to Identify 189 Global Engineering Fronts Released by Clarivate, the Chinese Academy of Engineering and the Higher Education Press of China
A comprehensive outlook on engineering innovations London, U.K. March 25, 2026. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, the Chinese Academy of Engineering (CAE) and the…